Physician profile
Divya Patel
NPI 1528498565
$4,213.66
in general payments reported to CMS, 2019-2025
13 companies · $1,388 in 2025
The $1,388 reported for 2025 was more than what 94% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $142 · 2020: $84.63 · 2021: $255 · 2022: $2,003 · 2023: $103 · 2024: $238 · 2025: $1,388.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $868 · Food and Beverage: $860.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $868.48 |
| Food and Beverage | $860.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $2,080.29 | 2019-2023 | Acuvue |
| Biotissue Holdings INC. | $1,212.04 | 2024-2025 | |
| Coopervision INC. | $217.37 | 2019-2023 | Myday Contact Lens |
| Alcon Vision LLC | $216.70 | 2019-2025 | Clareon, Total30, Hydrus Microstent |
| Abbvie INC. | $184.91 | 2024-2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $75.03 | 2019-2021 | |
| Carl Zeiss Meditec USA, INC. | $50.00 | 2024 | Cirrus Hd-Oct |
| Bausch & Lomb Americas INC. | $44.41 | 2022 | |
| Thea Pharma INC. | $40.62 | 2024-2025 | Iyuzeh |
| Dompe US, INC. | $33.86 | 2025 | Oxervate |
| Tarsus Pharmaceuticals, INC. | $20.86 | 2024 | Xdemvy |
| Oyster Point Pharma, INC. | $19.50 | 2023 | Tyrvaya |
| Glaukos Corporation | $18.07 | 2025 | Idosetr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Divya Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.